- Home
- Publications
- Publication Search
- Publication Details
Title
PPAR Agonists for the Prevention and Treatment of Lung Cancer
Authors
Keywords
-
Journal
PPAR Research
Volume 2017, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2017-02-21
DOI
10.1155/2017/8252796
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Risk factors for lung cancer worldwide
- (2016) Jyoti Malhotra et al. EUROPEAN RESPIRATORY JOURNAL
- Targeting roles of inflammatory microenvironment in lung cancer and metastasis
- (2015) Lin Shi et al. CANCER AND METASTASIS REVIEWS
- Chemotherapeutic Drugs Induce PPAR-γ Expression and Show Sequence-Specific Synergy with PPAR-γ Ligands in Inhibition of Non–Small Cell Lung Cancer
- (2015) Raju C. Reddy et al. NEOPLASIA
- A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research
- (2014) D. R. Brenner et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages
- (2014) Aravind T. Reddy et al. FASEB JOURNAL
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The Peroxisome Proliferator-Activated Receptor (PPAR) α Agonist Fenofibrate Suppresses Chemically Induced Lung Alveolar Proliferative Lesions in Male Obese Hyperlipidemic Mice
- (2014) Toshiya Kuno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PPARα Activation Can Help Prevent and Treat Non–Small Cell Lung Cancer
- (2013) Nataliya Skrypnyk et al. CANCER RESEARCH
- Invading one step at a time: the role of invadopodia in tumor metastasis
- (2013) H Paz et al. ONCOGENE
- Collagen as a double-edged sword in tumor progression
- (2013) Min Fang et al. TUMOR BIOLOGY
- Endothelial Cell Peroxisome Proliferator-Activated Receptor Reduces Endotoxemic Pulmonary Inflammation and Injury
- (2012) A. T. Reddy et al. JOURNAL OF IMMUNOLOGY
- PPARγExpression and Function in Mycobacterial Infection: Roles in Lipid Metabolism, Immunity, and Bacterial Killing
- (2012) Patricia E. Almeida et al. PPAR Research
- Biological Function and Prognostic Significance of Peroxisome Proliferator-Activated Receptor in Rectal Cancer
- (2011) L. Yang et al. CLINICAL CANCER RESEARCH
- Molecular cross-regulation between PPAR-γ and other signaling pathways: Implications for lung cancer therapy
- (2011) Ajaya Kumar Reka et al. LUNG CANCER
- The Nuclear Hormone Receptor PPARγas a Therapeutic Target in Major Diseases
- (2011) Martina Victoria Schmidt et al. TheScientificWorldJOURNAL
- Roles of Peroxisome Proliferator–Activated Receptor–α and –γ in the Development of Non–Small Cell Lung Cancer
- (2010) Ming-Yue Li et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Leukotriene B4Is a Physiologically Relevant Endogenous Peroxisome Proliferator-activated Receptor-α Agonist
- (2010) Venkata R. Narala et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemopreventive Effects of Pioglitazone on Chemically Induced Lung Carcinogenesis in Mice
- (2010) Y. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Cellular and Pharmacological Selectivity of the Peroxisome Proliferator-Activated Receptor- / Antagonist GSK3787
- (2010) P. S. Palkar et al. MOLECULAR PHARMACOLOGY
- GW0742, A HIGH-AFFINITY PPAR -β/δ AGONIST, INHIBITS ACUTE LUNG INJURY IN MICE
- (2010) Rosanna Di Paola et al. SHOCK
- Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
- (2009) Masayuki Shimoda et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Peroxisome Proliferator–Activated Receptor β/δ Expression and Activation in Lung Cancer
- (2008) Tetyana V. Pedchenko et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The Peroxisome Proliferator Activator Receptor Alpha/Delta Agonists Linoleic Acid and Bezafibrate Upregulate Osteoblast Differentiation and Induce Periosteal Bone Formation In Vivo
- (2008) Karen Still et al. CALCIFIED TISSUE INTERNATIONAL
- Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
- (2008) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Peroxisome Proliferator-Activated Receptor Pathway Targeting in Carcinogenesis: Implications for Chemoprevention
- (2008) F. Ondrey CLINICAL CANCER RESEARCH
- Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARβ/δ ligand GW0742
- (2008) Z. Haskova et al. INFLAMMATION RESEARCH
- Molecular recognition of nitrated fatty acids by PPARγ
- (2008) Yong Li et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- PPAR agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition
- (2008) D. Panigrahy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in human lung cancer cell lines
- (2008) Pengfei He et al. TOXICOLOGY
- PPARs Mediate Lipid Signaling in Inflammation and Cancer
- (2008) Liliane Michalik et al. PPAR Research
- The Role of PPARs in Cancer
- (2008) Keisuke Tachibana et al. PPAR Research
- Macrophages, PPARs, and Cancer
- (2008) Jo A. Van Ginderachter et al. PPAR Research
- PPAR-γ agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis
- (2007) Jami E. Milam et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now